Evidence map›Paper›PMID 35726821›Full record

ArticleBioengineered2022

Based on network pharmacology and in vitro experiments to prove the effective inhibition of myocardial fibrosis by Buyang Huanwu decoction.

Tianyue Wang, Xinyu Jiang, Yanmin Ruan, Jun Zhuang, Yuanjun Yin

Open access · goldAbstract read
In one paragraph

Article in Bioengineered, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
14.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Psoriasis intervention by Huai'er (): unveiling novel targetsnetwork pharmacology.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Exploring the anti‑oxidative mechanisms ofMolecular medicine reports · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tianyue WangThe 2nd Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China.ORCID 0000-0002-1037-1935
Xinyu JiangThe 1st Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China.ORCID 0000-0001-6820-231X
Yanmin RuanThe 2nd Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China.ORCID 0000-0001-5532-8642
Jun ZhuangThe 2nd Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China.ORCID 0000-0002-4782-3472
Yuanjun YinDepartment of Physiology, Zhejiang Chinese Medical University, Hangzhou, China.ORCID 0000-0002-1973-5176
Zhejiang Chinese Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among cardiovascular diseases, myocardial fibrosis (MF) is a major pathological change underlying heart failure and is associated with a high mortality rate. However, the molecular mechanism underlying MF has remained elusive. Buyang Huanwu decoction (BYHWD), a traditional Chinese medicine (TCM) formula for cardiovascular diseases, exhibits good anti-inflammatory and blood-activating properties. In the present study, we studied the MF inhibitory effect of BYHWD using network pharmacology and experimental validation. We used several databases to collect information on MF and related drugs and finally obtained cross-targets for BYHWD and MF. After that we got protein-protein interaction (PPI) network and performed gene ontology (GO) and Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analyses to obtain key signaling pathways for further study. After screening, interleukin (IL)-6, IL-1β, and matrix metallopeptidase 9 (MMP9) were selected for

Indexed as

Cardiovascular DiseasesDrugs, Chinese HerbalAnimalsFibrosisHumansInterleukin-17Molecular Docking SimulationNetwork PharmacologyRatsbuyang huanwuDrugs, Chinese HerbalInterleukin-17Buyang Huanwu decoctionIL-17 signaling pathwaymolecular dockingMyocardial fibrosisnetwork pharmacology

Identifiers

PMID35726821
PMCPMC9275964
OpenAlexW4283212322

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.